Latest Press Releases
November 22, 2023
Latest News Articles
October 30, 2023
Precision Medicine Online
AnHeart Inks Deal With Nippon Kayaku to Bring Taletrectinib to Lung Cancer Patients in Japan
April 3, 2023
Clinical Trials Arena
AnHeart Therapeutics reports data from ROS1+ NSCLC therapy trial
March 31, 2023
OncLive
Taletrectinib Elicits Durable Responses in TKI-Naïve and Crizotinib-Pretreated ROS1+ NSCLC
On November 8, 2022, Dr. Ross Camidge, Dr. Misako Nagasaka and Janet Freeman-Daily, the ROS1ders co-founder discussed the current and future treatment landscape including taletrectinib for ROS1+ NSCLC.
On June 7, 2022, Dr. Wei Li, Dr. Caicun Zhou, Dr. Ross Camidge, and Dr. Misako Nagasaka discussed taletrectinib TRUST-I interim data in ROS1+ NSCLC patients as published at ASCO2022.
On June 3, 2023, Dr. David Reardon, Dr. Fabio Iwamato, and Dr. Nicole Willmarth discussed the current and future treatment landscape in IDH-mutant glioma.
